Prostate Cancer

Top Story

World Cancer Day: ‘We can’ reduce global cancer burden

February 4, 2016

Today marks the annual observation of World Cancer Day, founded by the Union for International Cancer Control to raise awareness of cancer and emphasize the importance of prevention, detection and treatment.

The theme of this year’s observation — “We can. I can.” — is intended to illustrate the power individuals and society as a whole have to reduce the global cancer burden.

Memorial Sloan Kettering program focuses on cancer disparities among U.S. immigrants

February 1, 2016
Immigrants are considerably underserved in terms of health care in the United States. Memorial Sloan Kettering Cancer Center launched its Immigrant Health and Cancer…
In the Journals

Enzalutamide superior to bicalutamide for castration-resistant prostate cancer

January 29, 2016
The oral androgen receptor inhibitor enzalutamide significantly reduced the risk for prostate cancer progression or death compared with bicalutamide in patients with…
In the Journals

Bankruptcy increases risk for cancer mortality

January 28, 2016
Filing for bankruptcy protection after a cancer diagnosis appeared associated with an increased risk for death, according to the results of a registry study.Patients…
In the Journals

World Cancer Day: ‘We can’ reduce global cancer burden

February 4, 2016
Today marks the annual observation of World Cancer Day, founded by the Union for International Cancer Control to raise awareness of cancer and…

Memorial Sloan Kettering program focuses on cancer disparities among U.S. immigrants

February 1, 2016
Immigrants are considerably underserved in terms of health care in the United States. Memorial Sloan Kettering Cancer Center launched its Immigrant…
In the Journals

Enzalutamide superior to bicalutamide for castration-resistant prostate cancer

January 29, 2016
The oral androgen receptor inhibitor enzalutamide significantly reduced the risk for prostate cancer progression or death compared with bicalutamide…
In the Journals

Bankruptcy increases risk for cancer mortality

January 28, 2016
Filing for bankruptcy protection after a cancer diagnosis appeared associated with an increased risk for death, according to the results of a…
FDA News

FDA grants breakthrough therapy designation to Lynparza for certain types of prostate cancer

January 28, 2016
The FDA granted breakthrough therapy designation to olaparib for monotherapy treatment of BRCA1/2 or ATM-mutated metastatic castration-resistant…

Memorial Sloan Kettering Cancer Center announces appointments

January 27, 2016
Memorial Sloan Kettering Cancer Center announced the following awards and appointments:Kantoff is a medical oncologist and clinical researcher who…

ORIEN precision cancer initiative designed to do what no single center can achieve alone

January 26, 2016
The Oncology Research Information Exchange Network precision cancer research collaboration has added three new partners to the team: Rutgers Cancer…

NCCN awards grants for study of enzalutamide, volasertib

January 24, 2016
The National Comprehensive Cancer Network awarded research grants to eight investigators.Five investigators will receive grants to study the…
In the Journals

Costs of competing treatments for low-risk prostate cancer vary widely

January 22, 2016
Significant cost variations existed between competing treatments for low-risk prostate cancer from the time of diagnosis through treatment, according…

Breast cancer surgeon joins Henry Ford Health System

January 21, 2016
Lisa A. Newman, MD, MPH, has been named director of the breast cancer program at Henry Ford Health System.Newman will lead the system’s new…
More Headlines »
morganatic-roan